Related references
Note: Only part of the references are listed.In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models
Yi-Yong Baek et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)
Repurposing anticancer drugs for the management of COVID-19
Khalid El Bairi et al.
EUROPEAN JOURNAL OF CANCER (2020)
Dry eye disease: when to treat and when to refer
Quan Findlay et al.
AUSTRALIAN PRESCRIBER (2018)
Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis
N. Wahlgren et al.
JOURNAL OF INTERNAL MEDICINE (2017)
TFOS DEWS II pain and sensation report
Carlos Belmonte et al.
OCULAR SURFACE (2017)
TFOS DEWS II Management and Therapy Report
Lyndon Jones et al.
OCULAR SURFACE (2017)
The Pathophysiology of Dry Eye Disease What We Know and Future Directions for Research
Stephen C. Pflugfelder et al.
OPHTHALMOLOGY (2017)
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
Jose Manuel Benitez-Del-Castillo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Targeting Abl Kinases to Regulate Vascular Leak During Sepsis and Acute Respiratory Distress Syndrome
Alicia N. Rizzo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Perceptions of Dry Eye Disease Management in Current Clinical Practice
Jennifer F. Williamson et al.
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2014)
Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors
Peter Canning et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Discoidin domain receptors in disease
Corina M. Borza et al.
MATRIX BIOLOGY (2014)
The role and treatment of inflammation in dry eye disease
Ayse Yagci et al.
INTERNATIONAL OPHTHALMOLOGY (2014)
Imatinib Mesylate: An Innovation in Treatment of Autoimmune Diseases
Gholamreza Azizi et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2013)
Assessment of Vision-Related Quality of Life in Dry Eye Patients
Meiyan Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Clinical and in vitro studies of imatinib in advanced carcinoid tumors
James C. Yao et al.
CLINICAL CANCER RESEARCH (2007)
Sensing extracellular matrix: An update on discoidin domain receptor function
Wolfgang F. Vogel et al.
CELLULAR SIGNALLING (2006)
Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients
B Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Absolute bioavailability of imatinib (Glivec®) orally versus intravenous infusion
B Peng et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases
KK Eklund et al.
ANNALS OF MEDICINE (2003)
Discoidin domain receptor (DDR)1 and 2: Collagen-activated tyrosine kinase receptors in the cornea
RR Mohan et al.
EXPERIMENTAL EYE RESEARCH (2001)
Share Paper
